Catrin Tudur Smith
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
Smith, Catrin Tudur; Williamson, Paula; Jones, Ashley; Smyth, Alan R.; Hewer, Simon Langton; Gamble, Carrol
Alan R. Smyth
Simon Langton Hewer
Some level of monitoring is usually required during a clinical trial to protect the rights and safety of trial participants and to safeguard the quality and reliability of trial results. Although there is increasing support for the use of risk-proportionate approaches to achieve these aims, the variety of methods and lack of an empirical evidence base can present challenges for clinical trial practitioners.
This paper describes the monitoring methods and procedures that are utilised by a noncommercial clinical trials unit which coordinates a range of clinical trials across a variety of clinical areas with different associated risks.
Monitoring activities and approaches should be selected to be proportionate to the risks identified within a trial. A risk-proportionate approach to monitoring is described giving details of methods that may be considered by clinical trial practitioners during the development of a trial monitoring plan. An example risk assessment and corresponding monitoring plan for a low risk (type A in the Medicines and Healthcare Products Regulatory Agency (MHRA) classification system) pediatric trial is provided for illustration.
We present ideas for developing a monitoring plan for a clinical trial of an investigational medicinal product based on our experience. Alternative approaches may be relevant or preferable in other settings based on inherent risk.
Smith, C. T., Williamson, P., Jones, A., Smyth, A. R., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit. Trials, 15(127), https://doi.org/10.1186/1745-6215-15-127
|Journal Article Type||Article|
|Publication Date||Apr 16, 2014|
|Deposit Date||Feb 15, 2016|
|Publicly Available Date||Feb 15, 2016|
|Peer Reviewed||Peer Reviewed|
|Keywords||Monitoring, Central monitoring, On-site monitoring, Risk proportionate, Quality assurance|
Smith Trials 2014 Risk proportionate monitoring.pdf
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia
Future therapies for cystic fibrosis